1.
Dermatology
; 205(2): 172-3, 2002.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12218236
RESUMO
A tyrosine kinase inhibitor (STI571, Gleevec) has recently been applied in the treatment of chronic myeloid leukemia. We present the first reported case of pityriasis rosea occurring as a reaction to Gleevec in a woman with blast crisis of this disorder. It is suggested that although coincidental, this exanthem may be due to this agent.